Ameriprise’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-254,839
| Closed | -$17.3M | – | 3822 |
|
|
2019
Q3 | $17.3M | Buy |
254,839
+14,731
| +6% | +$1.01M | 0.01% | 1248 |
|
|
2019
Q2 | $14M | Buy |
240,108
+92,429
| +63% | +$5.48M | 0.01% | 1458 |
|
|
2019
Q1 | $10.3M | Buy |
147,679
+42,621
| +41% | +$3.16M | ﹤0.01% | 1677 |
|
|
2018
Q4 | $6.77M | Sell |
105,058
-93,658
| -47% | -$6.57M | ﹤0.01% | 1909 |
|
|
2018
Q3 | $14M | Sell |
198,716
-330,388
| -62% | -$19.3M | ﹤0.01% | 1600 |
|
|
2018
Q2 | $26.7M | Sell |
529,104
-982,863
| -65% | -$39M | 0.01% | 992 |
|
|
2018
Q1 | $47.3M | Buy |
1,511,967
+1,414,051
| +1,444% | +$46.9M | 0.02% | 688 |
|
|
2017
Q4 | $3.35M | Buy |
97,916
+11,192
| +13% | +$357K | ﹤0.01% | 2385 |
|
|
2017
Q3 | $2.78M | Buy |
86,724
+5,721
| +7% | +$180K | ﹤0.01% | 2439 |
|
|
2017
Q2 | $2.64M | Buy |
81,003
+30,089
| +59% | +$953K | ﹤0.01% | 2469 |
|
|
2017
Q1 | $1.6M | Sell |
50,914
-1,978
| -4% | -$58.5K | ﹤0.01% | 2682 |
|
|
2016
Q4 | $1.55M | Buy |
52,892
+34,466
| +187% | +$1.05M | ﹤0.01% | 2751 |
|
|
2016
Q3 | $533K | Buy |
+18,426
| New | +$513K | ﹤0.01% | 3172 |
|
|
2014
Q4 | – | Sell |
-110
| Closed | -$3K | – | 4718 |
|
|
2014
Q3 | $3K | Buy |
110
+60
| +120% | +$1.67K | ﹤0.01% | 5320 |
|
|
2014
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 5423 |
|
|
2014
Q1 | $1K | Sell |
50
-82
| -62% | -$2.35K | ﹤0.01% | 5217 |
|
|
2013
Q4 | $4K | Sell |
132
-961
| -88% | -$30.5K | ﹤0.01% | 4704 |
|
|
2013
Q3 | $34K | Sell |
1,093
-80
| -7% | -$2.67K | ﹤0.01% | 4043 |
|
|
2013
Q2 | $37K | Buy |
+1,173
| New | +$38.5K | ﹤0.01% | 3887 |
|
Ameriprise's GHDX Position: Q4 2019 in Review
Ameriprise sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 254,839 shares — an estimated $17.3M sold.
Ameriprise first reported a position in GHDX in Q2 2013 and held it in 19 quarters. The position peaked at $47.3M in Q1 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Ameriprise reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Ameriprise sold 254,839 Genomic Health, Inc. shares in Q4 2019, an estimated $17.3M.
- Ameriprise first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 19 quarters.
- Ameriprise's Genomic Health, Inc. position peaked at $47.3M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.